Post-treatment liver stiffness predicts complications, HCC in hepatitis C

SAN DIEGO — Liver stiffness assessment predicted liver-related complications and hepatocellular carcinoma development among patients with hepatitis C following direct-acting antiviral treatment, according to research.“HCV infection is one of the leading causes of cirrhosis, HCC and liver-related complications. Sustained virological response is achieved in 80% to 95% of chronic HCV patients treated with direct-acting antivirals, or DAAs,” Prooksa Anancheunsook, MD, a faculty member in gastroenterology at Chulalongkorn University and King Chulalongkorn Memorial Hospital inRead More

Related Articles